Massachusetts Financial Services’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-8,066
Closed -$1.78M 871
2023
Q2
$1.78M Sell
8,066
-190
-2% -$42.1K ﹤0.01% 718
2023
Q1
$1.85M Sell
8,256
-6,232
-43% -$1.54M ﹤0.01% 720
2022
Q4
$4.03M Buy
14,488
+307
+2% +$77.5K ﹤0.01% 669
2022
Q3
$2.97M Sell
14,181
-1,943
-12% -$434K ﹤0.01% 687
2022
Q2
$3.8M Buy
16,124
+316
+2% +$64.2K ﹤0.01% 672
2022
Q1
$2.84M Buy
15,808
+219
+1% +$41.7K ﹤0.01% 717
2021
Q4
$3.37M Sell
15,589
-5,888
-27% -$1.16M ﹤0.01% 718
2021
Q3
$3.96M Sell
21,477
-450
-2% -$88.6K ﹤0.01% 727
2021
Q2
$3.93M Sell
21,927
-9,688
-31% -$1.85M ﹤0.01% 727
2021
Q1
$5.29M Sell
31,615
-15,799
-33% -$2.63M ﹤0.01% 691
2020
Q4
$7.2M Sell
47,414
-1,091
-2% -$143K ﹤0.01% 658
2020
Q3
$4.9M Buy
48,505
+10,898
+29% +$1.2M ﹤0.01% 665
2020
Q2
$4.55M Buy
37,607
+7,330
+24% +$825K ﹤0.01% 639
2020
Q1
$2.87M Buy
30,277
+4,565
+18% +$434K ﹤0.01% 651
2019
Q4
$2.27M Sell
25,712
-2,159
-8% -$190K ﹤0.01% 703
2019
Q3
$2.22M Buy
27,871
+4,968
+22% +$400K ﹤0.01% 712
2019
Q2
$1.79M Buy
22,903
+3,629
+19% +$339K ﹤0.01% 745
2019
Q1
$2.26M Buy
19,274
+561
+3% +$65.4K ﹤0.01% 705
2018
Q4
$2.04M Buy
18,713
+1,324
+8% +$154K ﹤0.01% 705
2018
Q3
$2.22M Buy
17,389
+52
+0.3% +$6.43K ﹤0.01% 712
2018
Q2
$1.96M Sell
17,337
-887
-5% -$97.5K ﹤0.01% 715
2018
Q1
$2.05M Buy
18,224
+9,801
+116% +$1.25M ﹤0.01% 701
2017
Q4
$1.25M Buy
8,423
+1,621
+24% +$206K ﹤0.01% 735
2017
Q3
$797K Buy
+6,802
New +$869K ﹤0.01% 774
2016
Q4
Sell
-20,333
Closed -$2.4M 896
2016
Q3
$2.4M Buy
20,333
+6,181
+44% +$743K ﹤0.01% 711
2016
Q2
$1.5M Sell
14,152
-134
-0.9% -$14.9K ﹤0.01% 729
2016
Q1
$1.59M Buy
+14,286
New +$1.81M ﹤0.01% 710

Other funds holding UTHR